BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gilbert S, Zhang R, Denson L, Moriggl R, Steinbrecher K, Shroyer N, Lin J, Han X. Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation. EMBO Mol Med. 2012;4:109-124. [PMID: 22228679 DOI: 10.1002/emmm.201100192] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Connelly TM, Koltun WA, Berg AS, Hegarty JP, Brinton D, Deiling S, Poritz LS, Stewart DB. A single nucleotide polymorphism in the STAT5 gene favors colonic as opposed to small-bowel inflammation in Crohn's disease. Dis Colon Rectum. 2013;56:1068-1074. [PMID: 23929016 DOI: 10.1097/DCR.0b013e31829de128] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
2 Recoquillon S, Carusio N, Lagrue-Lakhal AH, Tual-Chalot S, Filippelli A, Andriantsitohaina R, Martinez MC. Interaction in endothelium of non-muscular myosin light-chain kinase and the NF-κB pathway is critical to lipopolysaccharide-induced vascular hyporeactivity. Clin Sci (Lond) 2015;129:687-98. [PMID: 26201020 DOI: 10.1042/CS20140625] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 He W, Wang Y, Wang P, Wang F. Intestinal barrier dysfunction in severe burn injury. Burns Trauma 2019;7:24. [PMID: 31372365 DOI: 10.1186/s41038-019-0162-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
4 Heneghan AF, Pierre JF, Kudsk KA. JAK-STAT and intestinal mucosal immunology. JAKSTAT. 2013;2:e25530. [PMID: 24416649 DOI: 10.4161/jkst.25530] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zhao HW, Yue YH, Han H, Chen XL, Lu YG, Zheng JM, Hou HT, Lang XM, He LL, Hu QL, Dun ZQ. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis. World J Gastroenterol 2017;23:999-1009. [PMID: 28246473 DOI: 10.3748/wjg.v23.i6.999] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
6 Zhang Y, Li X, Luo Z, Ma L, Zhu S, Wang Z, Wen J, Cheng S, Gu W, Lian Q, Zhao X, Fan W, Ling Z, Ye J, Zheng S, Li D, Wang H, Liu J, Sun B. ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation. Proc Natl Acad Sci U S A 2020;117:3083-92. [PMID: 31980528 DOI: 10.1073/pnas.1912774117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
7 Tao Y, Yue M, Lv C, Yun X, Qiao S, Fang Y, Wei Z, Xia Y, Dai Y. Pharmacological activation of ERβ by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases. FASEB J 2020;34:3069-90. [PMID: 31908053 DOI: 10.1096/fj.201901638RR] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Hedl M, Sun R, Huang C, Abraham C. STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and STAT3/STAT5 Disease Variants Modulate These Outcomes. J Immunol 2019;203:3325-38. [PMID: 31732533 DOI: 10.4049/jimmunol.1900031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Nobel YR, Stier K, Krishnareddy S. STAT signaling in the intestine. Int Rev Cell Mol Biol 2021;361:1-20. [PMID: 34074491 DOI: 10.1016/bs.ircmb.2021.02.001] [Reference Citation Analysis]
10 Drolia R, Tenguria S, Durkes AC, Turner JR, Bhunia AK. Listeria Adhesion Protein Induces Intestinal Epithelial Barrier Dysfunction for Bacterial Translocation. Cell Host Microbe 2018;23:470-484.e7. [PMID: 29606495 DOI: 10.1016/j.chom.2018.03.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 18.3] [Reference Citation Analysis]
11 Neurath MF. New targets for mucosal healing and therapy in inflammatory bowel diseases. Mucosal Immunol. 2014;7:6-19. [PMID: 24084775 DOI: 10.1038/mi.2013.73] [Cited by in Crossref: 192] [Cited by in F6Publishing: 180] [Article Influence: 24.0] [Reference Citation Analysis]
12 Wingelhofer B, Neubauer HA, Valent P, Han X, Constantinescu SN, Gunning PT, Müller M, Moriggl R. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer. Leukemia 2018;32:1713-26. [PMID: 29728695 DOI: 10.1038/s41375-018-0117-x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 68] [Article Influence: 27.3] [Reference Citation Analysis]
13 Zhao M, Xiong X, Ren K, Xu B, Cheng M, Sahu C, Wu K, Nie Y, Huang Z, Blumberg RS, Han X, Ruan HB. Deficiency in intestinal epithelial O-GlcNAcylation predisposes to gut inflammation. EMBO Mol Med 2018;10:e8736. [PMID: 29941542 DOI: 10.15252/emmm.201708736] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
14 Liu CY, Cham CM, Chang EB. Epithelial wound healing in inflammatory bowel diseases: the next therapeutic frontier. Transl Res 2021;236:35-51. [PMID: 34126257 DOI: 10.1016/j.trsl.2021.06.001] [Reference Citation Analysis]
15 Allam O, Samarani S, Mehraj V, Jenabian MA, Tremblay C, Routy JP, Amre D, Ahmad A. HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation. PLoS One 2018;13:e0194185. [PMID: 29601578 DOI: 10.1371/journal.pone.0194185] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
16 Wang L, Hu Y, Song B, Xiong Y, Wang J, Chen D. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease. Inflamm Res 2021;70:753-64. [PMID: 34212215 DOI: 10.1007/s00011-021-01482-x] [Reference Citation Analysis]
17 Neunlist M, Van Landeghem L, Mahé MM, Derkinderen P, des Varannes SB, Rolli-Derkinderen M. The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease. Nat Rev Gastroenterol Hepatol. 2013;10:90-100. [PMID: 23165236 DOI: 10.1038/nrgastro.2012.221] [Cited by in Crossref: 151] [Cited by in F6Publishing: 134] [Article Influence: 16.8] [Reference Citation Analysis]
18 Chakraborty N, Waning DL, Gautam A, Hoke A, Sowe B, Youssef D, Butler S, Savaglio M, Childress PJ, Kumar R, Moyler C, Dimitrov G, Kacena MA, Hammamieh R. Gene-Metabolite Network Linked to Inhibited Bioenergetics in Association With Spaceflight-Induced Loss of Male Mouse Quadriceps Muscle. J Bone Miner Res 2020;35:2049-57. [PMID: 32511780 DOI: 10.1002/jbmr.4102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
19 Zhang R, Gilbert S, Yao X, Vallance J, Steinbrecher K, Moriggl R, Zhang D, Eluri M, Chen H, Cao H, Shroyer N, Denson L, Han X. Natural compound methyl protodioscin protects against intestinal inflammation through modulation of intestinal immune responses. Pharmacol Res Perspect 2015;3:e00118. [PMID: 26038694 DOI: 10.1002/prp2.118] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
20 Liu R, Moriggl R, Zhang D, Li H, Karns R, Ruan HB, Niu H, Mayhew C, Watson C, Bangar H, Cha SW, Haslam D, Zhang T, Gilbert S, Li N, Helmrath M, Wells J, Denson L, Han X. Constitutive STAT5 activation regulates Paneth and Paneth-like cells to control Clostridium difficile colitis. Life Sci Alliance 2019;2:e201900296. [PMID: 30948494 DOI: 10.26508/lsa.201900296] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
21 Nighot P, Al-Sadi R, Rawat M, Guo S, Watterson DM, Ma T. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis. Am J Physiol Gastrointest Liver Physiol. 2015;309:G988-G997. [PMID: 26514773 DOI: 10.1152/ajpgi.00256.2015] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 9.8] [Reference Citation Analysis]
22 O'Malley G, Heijltjes M, Houston AM, Rani S, Ritter T, Egan LJ, Ryan AE. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? Oncotarget 2016;7:60752-74. [PMID: 27542276 DOI: 10.18632/oncotarget.11354] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
23 Young JA, Jensen EA, Stevens A, Duran-Ortiz S, List EO, Berryman DE, Kopchick JJ. Characterization of an intestine-specific GH receptor knockout (IntGHRKO) mouse. Growth Horm IGF Res 2019;46-47:5-15. [PMID: 31078722 DOI: 10.1016/j.ghir.2019.05.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
24 Soendergaard C, Young JA, Kopchick JJ. Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease. Int J Mol Sci 2017;18:E1019. [PMID: 28486400 DOI: 10.3390/ijms18051019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
25 Gilbert S, Nivarthi H, Mayhew CN, Lo YH, Noah TK, Vallance J, Rülicke T, Müller M, Jegga AG, Tang W, Zhang D, Helmrath M, Shroyer N, Moriggl R, Han X. Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration. Stem Cell Reports 2015;4:209-25. [PMID: 25579133 DOI: 10.1016/j.stemcr.2014.12.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
26 Prattis S, Jurjus A. Spontaneous and transgenic rodent models of inflammatory bowel disease. Lab Anim Res 2015;31:47-68. [PMID: 26155200 DOI: 10.5625/lar.2015.31.2.47] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
27 Pott J, Hornef M. Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep. 2012;13:684-698. [PMID: 22801555 DOI: 10.1038/embor.2012.96] [Cited by in Crossref: 113] [Cited by in F6Publishing: 104] [Article Influence: 12.6] [Reference Citation Analysis]
28 Yu X, Zeng K, Liu X, Peng Y, Li C, Fu K, Liang H. Increased expression of thymic stromal lymphopoietin receptor in a rat model of middle cerebral artery occlusion. Neuroreport 2019;30:182-7. [PMID: 30676545 DOI: 10.1097/WNR.0000000000001181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
29 Feng Y, Teitelbaum DH. Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition. J Physiol 2013;591:3709-23. [PMID: 23753529 DOI: 10.1113/jphysiol.2013.253518] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
30 Galien R. Janus kinases in inflammatory bowel disease: Four kinases for multiple purposes. Pharmacological Reports 2016;68:789-96. [DOI: 10.1016/j.pharep.2016.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
31 Surbek M, Tse W, Moriggl R, Han X. A centric view of JAK/STAT5 in intestinal homeostasis, infection, and inflammation. Cytokine 2021;139:155392. [PMID: 33482575 DOI: 10.1016/j.cyto.2020.155392] [Reference Citation Analysis]
32 Lee H, Son YS, Lee MO, Ryu JW, Park K, Kwon O, Jung KB, Kim K, Ryu TY, Baek A, Kim J, Jung CR, Ryu CM, Park YJ, Han TS, Kim DS, Cho HS, Son MY. Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways. Theranostics 2020;10:5048-63. [PMID: 32308767 DOI: 10.7150/thno.41534] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
33 Weber A, Borghouts C, Brendel C, Moriggl R, Delis N, Brill B, Vafaizadeh V, Groner B. The inhibition of stat5 by a Peptide aptamer ligand specific for the DNA binding domain prevents target gene transactivation and the growth of breast and prostate tumor cells. Pharmaceuticals (Basel) 2013;6:960-87. [PMID: 24276378 DOI: 10.3390/ph6080960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
34 Chen Y, Jiang W, Liu Y, Jiang J, Wu P, Zhao J, Kuang S, Tang L, Tang W, Zhang Y, Zhou X, Feng L. Exogenous phospholipids supplementation improves growth and modulates immune response and physical barrier referring to NF-κB, TOR, MLCK and Nrf2 signaling factors in the intestine of juvenile grass carp ( Ctenopharyngodon idella ). Fish & Shellfish Immunology 2015;47:46-62. [DOI: 10.1016/j.fsi.2015.08.024] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 10.2] [Reference Citation Analysis]
35 Logotheti S, Pützer BM. STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases. Cancers (Basel) 2019;11:E1448. [PMID: 31569642 DOI: 10.3390/cancers11101448] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Lan A, Blachier F, Benamouzig R, Beaumont M, Barrat C, Coelho D, Lancha A Jr, Kong X, Yin Y, Marie JC, Tomé D. Mucosal healing in inflammatory bowel diseases: is there a place for nutritional supplementation? Inflamm Bowel Dis 2015;21:198-207. [PMID: 25208104 DOI: 10.1097/MIB.0000000000000177] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
37 Lee Y, Choo J, Kim SJ, Heo G, Pothoulakis C, Kim YH, Im E. Analysis of endogenous lipids during intestinal wound healing. PLoS One 2017;12:e0183028. [PMID: 28800645 DOI: 10.1371/journal.pone.0183028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
38 Kim CK, Yang VW, Bialkowska AB. The Role of Intestinal Stem Cells in Epithelial Regeneration Following Radiation-Induced Gut Injury. Curr Stem Cell Rep 2017;3:320-32. [PMID: 29497599 DOI: 10.1007/s40778-017-0103-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
39 Chiriac MT, Buchen B, Wandersee A, Hundorfean G, Günther C, Bourjau Y, Doyle SE, Frey B, Ekici AB, Büttner C, Weigmann B, Atreya R, Wirtz S, Becker C, Siebler J, Neurath MF. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease. Gastroenterology 2017;153:123-138.e8. [PMID: 28342759 DOI: 10.1053/j.gastro.2017.03.015] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]
40 Soendergaard C, Kvist PH, Thygesen P, Reslow M, Nielsen OH, Kopchick JJ, Holm TL. Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis. Int J Mol Sci. 2017;18:2046. [PMID: 28946616 DOI: 10.3390/ijms18102046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
41 Dupaul-Chicoine J, Dagenais M, Saleh M. Crosstalk between the intestinal microbiota and the innate immune system in intestinal homeostasis and inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2227-2237. [PMID: 23669404 DOI: 10.1097/mib.0b013e31828dcac7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 5.9] [Reference Citation Analysis]